Department of Organ Interaction Research Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan.
Transplantation. 2010 Jun 15;89(11):1391-5. doi: 10.1097/tp.0b013e3181d9e17b.
Because of lack of deceased donors in Japan, there has been a need to expand the eligibility criteria for live kidney donation. To assess the indications for live kidney donation in glucose intolerance (GI), we analyzed perioperative complications associated with donor nephrectomies performed at our institution and followed up the long-term consequences.
The 444 live kidney donors were divided into two groups based on the results of the 75-g oral glucose tolerance test: a GI group (n=71) who showed a diabetic (n=27) or impaired glucose tolerance (n=44) pattern, and a non-GI group (n=373) who showed a normal oral glucose tolerance test pattern. Perioperative complications, longterm survival rate, and frequencies of hypertension, diabetes, hyperlipidemia, and renal dysfunction in long term were compared in each group.
The incidence of perioperative complications was not higher in the GI group than in the non-GI group (4.3% vs. 5.4%, respectively; NS). Survival rates in the GI group at 5, 10, and 20 years were 98.3%, 95.1%, and 89.2%, respectively, whereas those in the non-GI group were 98.0%, 96.1%, and 91.5%, thus showing equivalent mortality. None of the patients in the diabetes mellitus group had developed severe diabetic complications or end-stage renal disease at a mean follow-up point of 88+/-71 (range, 14-225) months.
Our results suggest that individuals who have GI without diabetic complication may be able to donate their kidney safely with little surgical complication and little major morbidity if strict evaluation is performed before transplant.
由于日本缺乏已故捐赠者,因此需要扩大活体肾脏捐献的资格标准。为了评估葡萄糖耐量异常(GI)患者进行活体肾脏捐献的适应症,我们分析了在我们机构进行的供肾切除术相关的围手术期并发症,并随访了长期后果。
根据 75 克口服葡萄糖耐量试验的结果,将 444 名活体肾脏供者分为两组:GI 组(n=71)表现为糖尿病(n=27)或糖耐量受损(n=44)模式,非 GI 组(n=373)表现为正常口服葡萄糖耐量试验模式。比较每组的围手术期并发症、长期生存率以及高血压、糖尿病、高血脂和肾功能不全的长期频率。
GI 组的围手术期并发症发生率并不高于非 GI 组(分别为 4.3%和 5.4%;NS)。GI 组在 5、10 和 20 年的生存率分别为 98.3%、95.1%和 89.2%,而非 GI 组分别为 98.0%、96.1%和 91.5%,因此死亡率相当。在平均随访 88+/-71(范围,14-225)个月后,糖尿病组中没有患者出现严重的糖尿病并发症或终末期肾病。
我们的结果表明,没有糖尿病并发症的 GI 个体如果在移植前进行严格评估,可能能够安全地捐献肾脏,手术并发症少,主要发病率低。